"Colorado Springs Neurological Associates (CSNA) was founded in 1959 and today is the largest, most experienced neuroscience practice in Southern Colorado. We’re an experienced group of neurologists, neurosurgeons, neurophysiologists, and pain management specialists working in concert to provide superior neurological testing, evaluation, interpretation, and treatment. CSNA’s infusion center provides comprehensive, skilled nursing services for patients undergoing outpatient diagnostic and therapeutic intravenous procedures. The research department at Colorado Springs Neurological Associates was established in 2011. In addition to clinical trials, we generate our own research ideas and develop protocols to answer scientific questions."

During the past decade, Colorado Springs Neurological Associates conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 11 clinical trials were completed, i.e. on average, 30.6% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 9 clinical trials were completed. i.e. 45% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Colorado Springs Neurological Associates" #1 sponsor was "Allergan" with 4 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Pfizer" with 3 trials sponsored, "Theravance Biopharma" with 3 trials sponsored and "Amgen" with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Colorado Springs Neurological Associates" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Novartis" with 2 trials as a collaborator, "EMD Serono" with 1 trials as a collaborator, "H. Lundbeck A/S" with 1 trials as a collaborator and "Mallinckrodt ARD Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Colorado Springs Neurological Associates" are "Migraine" (7 trials), "Multiple Sclerosis" (5 trials), "Symptomatic Neurogenic Orthostatic Hypotension" (4 trials), "Amyotrophic Lateral Sclerosis" (2 trials) and "Episodic Migraine" (2 trials). Many other conditions were trialed in "Colorado Springs Neurological Associates" in a lesser frequency.

Most popular intervention types in "Colorado Springs Neurological Associates" are "Drug" (33 trials), "Other" (3 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "ampreloxetine" (3 trials), "Atogepant" (2 trials), "Cladribine Tablets" (2 trials) and "Erenumab Dose 1" (2 trials). Other intervention names were less common.

The vast majority of trials in "Colorado Springs Neurological Associates" are 39 trials for "All" genders.

Currently, there are NaN active trials in "Colorado Springs Neurological Associates". undefined are not yet recruiting, 11 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Colorado Springs Neurological Associates, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Colorado Springs Neurological Associates, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".